Review: taking Bisoprolol fumarate and Digoxin together


Summary

Drug interactions are reported among people who take Bisoprolol fumarate and Digoxin together. This review analyzes the effectiveness and drug interactions between Bisoprolol fumarate and Digoxin. It is created by eHealthMe based on reports of 2,492 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Bisoprolol Fumarate

Bisoprolol fumarate has active ingredients of bisoprolol fumarate. It is often used in high blood pressure. (latest outcomes from Bisoprolol fumarate 16,948 users)

Digoxin

Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. (latest outcomes from Digoxin 65,301 users)

On Sep, 19, 2016

2,492 people who take Bisoprolol Fumarate, Digoxin are studied.


Number of reports submitted per year:

Bisoprolol fumarate and Digoxin drug interactions.

Drug effectiveness over time:

Bisoprolol Fumarate:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 33.0% - (1 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 0.0% - (0 of 2 people)
  • 2 - 5 years: 50.0% - (5 of 10 people)
  • 5 - 10 years: 75.0% - (3 of 4 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Digoxin:
  • < 1 month: 0.0% - (0 of 2 people)
  • 1 - 6 months: 66.0% - (2 of 3 people)
  • 6 - 12 months: 0.0% - (0 of 2 people)
  • 1 - 2 years: 0.0% - (0 of 1 people)
  • 2 - 5 years: 66.0% - (6 of 9 people)
  • 5 - 10 years: 50.0% - (1 of 2 people)
  • 10+ years: 75.0% - (3 of 4 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Bisoprolol Fumarate:
  • female: 44.0% - (4 of 9 people)
  • male: 46.0% - (6 of 13 people)
Digoxin:
  • female: 50.0% - (5 of 10 people)
  • male: 53.0% - (7 of 13 people)

Drug effectiveness by age:

Bisoprolol Fumarate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 33.0% - (1 of 3 people)
  • 50-59: 80.0% - (4 of 5 people)
  • 60+: 30.0% - (4 of 13 people)
Digoxin:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 100.0% - (1 of 1 people)
  • 40-49: 66.0% - (2 of 3 people)
  • 50-59: 80.0% - (4 of 5 people)
  • 60+: 35.0% - (5 of 14 people)

Most common drug interactions over time *:

< 1 month:
  • bradycardia
  • dyspnoea
  • atrial fibrillation
  • hypotension
  • renal failure acute
  • nausea
  • cardiac failure
  • fall
  • bronchopneumonia
  • transient ischaemic attack
1 - 6 months:
  • dyspnoea
  • fall
  • fatigue
  • abdominal pain
  • bradycardia
  • discomfort
  • feeling abnormal
  • headache
  • renal failure acute
  • subdural haematoma
6 - 12 months:
  • hypotension
  • hyperkalaemia
  • syncope
  • dyspnoea
  • renal failure acute
  • anaemia
  • cardiac failure
  • international normalised ratio increased
  • loss of consciousness
  • pulmonary oedema
1 - 2 years:
  • arrhythmia
  • hyperkalaemia
  • atrial fibrillation
  • bradycardia
  • palpitations
  • breathlessness
  • hyperkinetic heart syndrome
  • sick sinus syndrome
  • weakness
  • asthenia
2 - 5 years:
  • bradycardia
  • cloudy cornea
  • eyes - sensitive to light
  • asthenia
  • dehydration
  • atrial fibrillation
  • burping
  • jugular vein distension
  • taste loss
  • international normalised ratio increased
5 - 10 years:
  • atrial fibrillation
  • dyspnoea
  • pain
  • anxiety
  • hypotension
  • syncope
  • anhedonia
  • atrioventricular block complete
  • fluid overload
  • renal failure acute
10+ years:
  • dizziness
  • sepsis
  • cardiac failure
  • drowsiness
  • hepatocellular injury
  • memory impairment
  • overdose
  • renal failure chronic
  • sleep disorder due to general medical condition, insomnia type
  • atrial fibrillation
not specified:
  • atrial fibrillation
  • dyspnoea
  • dizziness
  • fatigue
  • renal failure acute
  • international normalised ratio increased
  • ventricular tachycardia
  • cardiac failure
  • oedema peripheral
  • fall

Most common drug interactions by gender *:

female:
  • atrial fibrillation
  • dyspnoea
  • international normalised ratio increased
  • bradycardia
  • fall
  • renal failure acute
  • diarrhoea
  • cardiac failure
  • malaise
  • death
male:
  • atrial fibrillation
  • dyspnoea
  • dizziness
  • fatigue
  • ventricular tachycardia
  • paraesthesia
  • cardiac murmur
  • renal failure acute
  • feeling abnormal
  • oedema peripheral

Most common drug interactions by age *:

0-1:
  • chapped lips
  • cleft palate
2-9:
  • ascites
  • foetal exposure during pregnancy
  • hepatic cirrhosis
  • renal impairment
  • type 1 diabetes mellitus
  • ventricular extrasystoles
  • weight decreased
20-29:
  • amenorrhoea
  • sperm concentration decreased
  • bradycardia
  • cardio-respiratory arrest
  • hypotension
  • nausea
  • overdose
  • red blood cell count decreased
  • sinus tachycardia
  • thyroid cyst
30-39:
  • anhedonia
  • anxiety
  • back pain
  • hunger
  • injury
  • pain
  • therapeutic agent toxicity
  • ventricular tachycardia
  • cardiac failure congestive
  • cardiomyopathy
40-49:
  • alanine aminotransferase increased
  • hypocalcaemia
  • tetany
  • nausea
  • diarrhoea
  • hepatic cirrhosis
  • cardiac failure congestive
  • cloudy cornea
  • eyes - sensitive to light
  • platelet count decreased
50-59:
  • diarrhoea
  • abdominal pain
  • anxiety
  • atrial fibrillation
  • pain
  • hyperkalaemia
  • hypertension
  • syncope
  • anhedonia
  • atrioventricular block complete
60+:
  • dyspnoea
  • atrial fibrillation
  • dizziness
  • fatigue
  • renal failure acute
  • international normalised ratio increased
  • fall
  • bradycardia
  • paraesthesia
  • ventricular tachycardia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Bisoprolol fumarate and Digoxin?

Can you answer these questions?

More questions for: Bisoprolol fumarate, Digoxin

You may be interested in these reviews

More reviews for: Bisoprolol fumarate, Digoxin

On eHealthMe, Bisoprolol fumarate (bisoprolol fumarate) is often used to treat high blood pressure. Digoxin (digoxin) is often used to treat atrial fibrillation/flutter. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.